NCT03462732

Brief Summary

The value of this study is to compare between stented endotracheal tube with nelaton catheter and non stented tube as regard nasotracheal related complications as epistaxis and nasal cavity injury.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2018

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

February 24, 2018

Completed
17 days until next milestone

First Posted

Study publicly available on registry

March 13, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

May 19, 2020

Status Verified

May 1, 2020

Enrollment Period

5 months

First QC Date

February 24, 2018

Last Update Submit

May 18, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • incidence and severity of Epistaxis

    An independent anesthesiologist who did not observe the tube insertion will assess the incidence and severity of epistaxis using a laryngoscope immediately after tube passage through the nasal cavity , four grades to evaluate epistaxis 1- no epistaxis 2- mild epistaxis ,blood apparent on the surface of the tube 3-moderate epistaxis pooling of blood on the posterior pharyngeal wall 4- severe epistaxis , large amount of blood in the pharynx impeding nasotracheal intubation and necessitating urgent orotracheal intubation.

    immediately after nasotracheal intubation

Secondary Outcomes (1)

  • Histopathology of the endotracheal tube contents after extubation

    immediately after extubation

Study Arms (2)

Group I

ACTIVE COMPARATOR

Endotracheal tube plus Nelaton catheter

Device: Endotracheal tubeDevice: Nelaton catheter

Group II

ACTIVE COMPARATOR

Endotracheal tube

Device: Endotracheal tube

Interventions

Nasotracheal intubation will be done with endotracheal tube

Group IGroup II

plus nelaton catheter

Also known as: Stent
Group I

Eligibility Criteria

Age3 Years - 9 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Pediatric patients scheduled for dental surgery under general anesthesia age 3-9 years
  • physical status American society of Anesthesiologist(ASA) I orII

You may not qualify if:

  • History of recurrent epistaxis
  • Coagulopathy
  • Previous nasal surgery
  • History of nasal trauma
  • Severe renal , hepatic or cardiovascular disease
  • History of drug allergy to the drugs used in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University hospitals

Cairo, 11591, Egypt

Location

MeSH Terms

Interventions

Stents

Intervention Hierarchy (Ancestors)

Prostheses and ImplantsEquipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 24, 2018

First Posted

March 13, 2018

Study Start

February 10, 2018

Primary Completion

July 1, 2018

Study Completion

August 1, 2018

Last Updated

May 19, 2020

Record last verified: 2020-05

Locations